So they developed a small company in California called Amylin Pharmaceuticals, they developed with a bit of help from Eli Lilly, they developed exendin four for diabetes therapy, and it was approved in 2005
That thing about a glass of red wine being good for your heart
The abdomen has slightly faster absorption in clinical data, but the difference is not clinically significant for most patients
In June 2025, a large study of older adults with Type 2 diabetes found those who took a GLP-1 drug mostly semaglutide had a "substantially higher risk" of developing wet age-related macular degeneration, a rare type of the disease, than people with diabetes who didn't take the medication
Persistent infection of human thymic epithelial cells by coxsackievirus B4
Our physicians have a long history of making recoveries as comfortable and easy as possible